Intensity modulated radiotherapy (IMRT) can reduce the dose to surrounding organs and healthy tissue for non–small cell lung cancer (NCSLC) patients beyond what is achievable with conventional radiotherapy. We report favourable toxicity outcomes including
There are no comments for this item.